4
Changes in Ownership
Cardiff Oncology, Inc. Filed Acc 0001628280-21-018433
Chief Financial Officer bought 30,000 shares at an average $6.47 ($194,000)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Levine James E. Chief Financial Officer | 2021-09-10 | Purchase | +5,000 | $6.62 | $33,100 | 5,000 | D |
| Levine James E. Chief Financial Officer | 2021-09-10 | Purchase | +5,000 | $6.75 | $33,750 | 10,000 | D |
| Levine James E. Chief Financial Officer | 2021-09-10 | Purchase | +10,000 | $6.38 | $63,800 | 20,000 | D |
| Levine James E. Chief Financial Officer | 2021-09-10 | Purchase | +5,000 | $6.35 | $31,750 | 25,000 | D |
| Levine James E. Chief Financial Officer | 2021-09-10 | Purchase | +5,000 | $6.32 | $31,600 | 30,000 | D |
| Open-market purchases · 30,000 sh · avg $6.47 · $194,000 | |||||||
Loading xslF345X03/wf-form4_163153514276157.xml…